![Jing Rong Jean Cui](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jing Rong Jean Cui
Gründer bei
BLOSSOMHILL THERAPEUTICS, INC.
Profil
Dr. Jing Rong Jean Cui is a President, CEO, Director & Scientific Founder at Blossomhill Therapeutics, Inc. She is on the Board of Directors at Blossomhill Therapeutics, Inc. Dr. Jean Cui also served on the board at Turning Point Therapeutics, Inc. She received her undergraduate degree from the University of Science & Technology of China, a graduate degree from the University of Science & Technology of China and a doctorate degree from The Ohio State University.
Aktive Positionen von Jing Rong Jean Cui
| Unternehmen | Position | Beginn |
|---|---|---|
| BLOSSOMHILL THERAPEUTICS, INC. | Gründer | 01.06.2020 |
Ehemalige bekannte Positionen von Jing Rong Jean Cui
| Unternehmen | Position | Ende |
|---|---|---|
| TURG POIN | Gründer | 15.06.2020 |
Ausbildung von Jing Rong Jean Cui
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
39
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage structure based drug design company for cancer diseases | Health Technology |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Science & Technology of China
 University of Science & Technology of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for oncology and autoimmune diseases | Health Technology |
